Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.
暂无分享,去创建一个
Elodie Portales-Casamar | Pascal Barbry | Wyeth W Wasserman | Bernard Mari | Christine Chomienne | Guillaume Vetter | Anne Saumet | Charles-Henri Lecellier | Evelyne Friederich | Bruno Cassinat | W. Wasserman | E. Portales-Casamar | P. Barbry | B. Mari | T. Maurin | C. Lecellier | L. Vallar | A. Saumet | C. Chomienne | K. Arar | G. Vetter | E. Friederich | Laurent Vallar | B. Cassinat | Thomas Maurin | Manuella Bouttier | Khalil Arar | M. Bouttier
[1] Bob Löwenberg,et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.
[2] Torsten Haferlach,et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin , 2008, Proceedings of the National Academy of Sciences.
[3] Zhen-yi Wang,et al. Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.
[4] G. Behre,et al. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. , 2008, Blood.
[5] D. Tenen,et al. Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha. , 2008, Blood.
[6] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[7] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[8] B. Frey,et al. Using expression profiling data to identify human microRNA targets , 2007, Nature Methods.
[9] F. Lo‐Coco,et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. , 2007, Cancer cell.
[10] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[11] A. Armugam,et al. MicroRNAs as therapeutic targets in human diseases , 2007, Expert opinion on therapeutic targets.
[12] R. Nasr,et al. RXR is an essential component of the oncogenic PML/RARA complex in vivo. , 2007, Cancer cell.
[13] C. Croce,et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia , 2007, Oncogene.
[14] Shaun Mahony,et al. Regulatory conservation of protein coding and microRNA genes in vertebrates: lessons from the opossum genome , 2007, Genome biology.
[15] L. Manchon,et al. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. , 2007, Blood.
[16] Yoko Fukuda,et al. An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling , 2007, Cell.
[17] T Chaplin,et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis , 2007, Leukemia.
[18] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[19] Zhao-yue Wang,et al. [The fibrinolytic activity in leukemic cell lines and its alteration on all-trans retinoic acid treatment]. , 2006, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[20] Jin-Wu Nam,et al. Genomics of microRNA. , 2006, Trends in genetics : TIG.
[21] Alessandro Fatica,et al. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.
[22] K. Livak,et al. Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.
[23] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[24] Charles Auffray,et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Graf,et al. High expression of urokinase plasminogen activator receptor (UPA‐R) in acute myeloid leukemia (AML) is associated with worse prognosis , 2005, American journal of hematology.
[26] A. Sandelin,et al. Prediction of nuclear hormone receptor response elements. , 2005, Molecular endocrinology.
[27] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[28] D. Bartel,et al. MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.
[29] H. de Thé,et al. PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation , 2004, The Journal of experimental medicine.
[30] J. Bastien,et al. Nuclear retinoid receptors and the transcription of retinoid-target genes. , 2004, Gene.
[31] M. Lanotte,et al. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation , 2004, Leukemia.
[32] S. Aref,et al. Urokinase Plasminogen Activator Receptor and Soluble Matrix Metalloproteinase-9 in Acute Myeloid Leukemia Patients: A Possible Relation to Disease Invasion , 2003, Hematology.
[33] J. She,et al. Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells. , 2003, The Journal of molecular diagnostics : JMD.
[34] V. Kim,et al. The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.
[35] Ki-Hwan Lee,et al. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. , 2002, Biochemical and biophysical research communications.
[36] S. Chevret,et al. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. , 2001, Blood.
[37] P. Knoepfler,et al. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation , 2001, Oncogene.
[38] M. Lanotte,et al. A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities , 2000, Leukemia.
[39] C. Meijer,et al. The role of Homeobox genes in normal hematopoiesis and hematological malignancies , 1999, Leukemia.
[40] S. Mustjoki,et al. Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells , 1998, Leukemia.
[41] B. Hoffman,et al. Lineage-specific regulation of hematopoiesis by HOX-B8 (HOX-2.4): inhibition of granulocytic differentiation and potentiation of monocytic differentiation. , 1997, Blood.
[42] M. Lanotte,et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Vaheri,et al. Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors. , 1994, Blood.
[44] Christine Chomienne,et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.
[45] R Berger,et al. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). , 1991, Blood.
[46] H. Stunnenberg,et al. Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.
[47] W. Hiddemann,et al. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. , 2008, Blood.
[48] P. Choong,et al. The urokinase plasminogen activator receptor as a gene therapy target for cancer. , 2007, Trends in biotechnology.
[49] T. Naoe,et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. , 1996, Blood.
[50] Najman,et al. NB 4 , a Maturation Inducible Cell Line With t ( 15 ; 17 ) Marker Isolated From a Human Acute Promyelocytic Leukemia ( M 3 ) , 2022 .